Cargando…
Vitamin D deficiency in critically ill COVID-19 ARDS patients
BACKGROUND & AIMS: Vitamin D's pleiotropic effects include immune modulation, and its supplementation has been shown to prevent respiratory tract infections. The effectivity of vitamin D as a therapeutic intervention in critical illness remains less defined. The current study analyzed clini...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and European Society for Clinical Nutrition and Metabolism.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937427/ https://www.ncbi.nlm.nih.gov/pubmed/33745749 http://dx.doi.org/10.1016/j.clnu.2021.03.001 |
_version_ | 1783661389285425152 |
---|---|
author | Notz, Quirin Herrmann, Johannes Schlesinger, Tobias Kranke, Peter Sitter, Magdalena Helmer, Philipp Stumpner, Jan Roeder, Daniel Amrein, Karin Stoppe, Christian Lotz, Christopher Meybohm, Patrick |
author_facet | Notz, Quirin Herrmann, Johannes Schlesinger, Tobias Kranke, Peter Sitter, Magdalena Helmer, Philipp Stumpner, Jan Roeder, Daniel Amrein, Karin Stoppe, Christian Lotz, Christopher Meybohm, Patrick |
author_sort | Notz, Quirin |
collection | PubMed |
description | BACKGROUND & AIMS: Vitamin D's pleiotropic effects include immune modulation, and its supplementation has been shown to prevent respiratory tract infections. The effectivity of vitamin D as a therapeutic intervention in critical illness remains less defined. The current study analyzed clinical and immunologic effects of vitamin D levels in patients suffering from coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS). METHODS: This was a single-center retrospective study in patients receiving intensive care with a confirmed SARS-CoV-2 infection and COVID-19 ARDS. 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum levels, pro- and anti-inflammatory cytokines and immune cell subsets were measured on admission as well as after 10–15 days. Clinical parameters were extracted from the patient data management system. Standard operating procedures included the daily administration of vitamin D(3) via enteral feeding. RESULTS: A total of 39 patients with COVID-19 ARDS were eligible, of which 26 were included in this study as data on vitamin D status was available. 96% suffered from severe COVID-19 ARDS. All patients without prior vitamin D supplementation (n = 22) had deficient serum levels of 25-hydroxyvitamin D. Vitamin D supplementation resulted in higher serum levels of 25-hydroxyvitamin D but not did not increase 1,25-dihydroxyvitamin D levels after 10–15 days. Clinical parameters did not differ between patients with sufficient or deficient levels of 25-hydroxyvitamin D. Only circulating plasmablasts were higher in patients with 25-hydroxyvitamin D levels ≥30 ng/ml (p = 0.029). Patients with 1,25-dihydroxyvitamin D levels below 20 pg/ml required longer mechanical ventilation (p = 0.045) and had a worse acute physiology and chronic health evaluation (APACHE) II score (p = 0.048). CONCLUSION: The vast majority of COVID-19 ARDS patients had vitamin D deficiency. 25-hydroxyvitamin D status was not related to changes in clinical course, whereas low levels of 1,25-dihydroxyvitamin D were associated with prolonged mechanical ventilation and a worse APACHE II score. |
format | Online Article Text |
id | pubmed-7937427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79374272021-03-08 Vitamin D deficiency in critically ill COVID-19 ARDS patients Notz, Quirin Herrmann, Johannes Schlesinger, Tobias Kranke, Peter Sitter, Magdalena Helmer, Philipp Stumpner, Jan Roeder, Daniel Amrein, Karin Stoppe, Christian Lotz, Christopher Meybohm, Patrick Clin Nutr Covid-19 BACKGROUND & AIMS: Vitamin D's pleiotropic effects include immune modulation, and its supplementation has been shown to prevent respiratory tract infections. The effectivity of vitamin D as a therapeutic intervention in critical illness remains less defined. The current study analyzed clinical and immunologic effects of vitamin D levels in patients suffering from coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS). METHODS: This was a single-center retrospective study in patients receiving intensive care with a confirmed SARS-CoV-2 infection and COVID-19 ARDS. 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum levels, pro- and anti-inflammatory cytokines and immune cell subsets were measured on admission as well as after 10–15 days. Clinical parameters were extracted from the patient data management system. Standard operating procedures included the daily administration of vitamin D(3) via enteral feeding. RESULTS: A total of 39 patients with COVID-19 ARDS were eligible, of which 26 were included in this study as data on vitamin D status was available. 96% suffered from severe COVID-19 ARDS. All patients without prior vitamin D supplementation (n = 22) had deficient serum levels of 25-hydroxyvitamin D. Vitamin D supplementation resulted in higher serum levels of 25-hydroxyvitamin D but not did not increase 1,25-dihydroxyvitamin D levels after 10–15 days. Clinical parameters did not differ between patients with sufficient or deficient levels of 25-hydroxyvitamin D. Only circulating plasmablasts were higher in patients with 25-hydroxyvitamin D levels ≥30 ng/ml (p = 0.029). Patients with 1,25-dihydroxyvitamin D levels below 20 pg/ml required longer mechanical ventilation (p = 0.045) and had a worse acute physiology and chronic health evaluation (APACHE) II score (p = 0.048). CONCLUSION: The vast majority of COVID-19 ARDS patients had vitamin D deficiency. 25-hydroxyvitamin D status was not related to changes in clinical course, whereas low levels of 1,25-dihydroxyvitamin D were associated with prolonged mechanical ventilation and a worse APACHE II score. Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. 2022-12 2021-03-07 /pmc/articles/PMC7937427/ /pubmed/33745749 http://dx.doi.org/10.1016/j.clnu.2021.03.001 Text en © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Covid-19 Notz, Quirin Herrmann, Johannes Schlesinger, Tobias Kranke, Peter Sitter, Magdalena Helmer, Philipp Stumpner, Jan Roeder, Daniel Amrein, Karin Stoppe, Christian Lotz, Christopher Meybohm, Patrick Vitamin D deficiency in critically ill COVID-19 ARDS patients |
title | Vitamin D deficiency in critically ill COVID-19 ARDS patients |
title_full | Vitamin D deficiency in critically ill COVID-19 ARDS patients |
title_fullStr | Vitamin D deficiency in critically ill COVID-19 ARDS patients |
title_full_unstemmed | Vitamin D deficiency in critically ill COVID-19 ARDS patients |
title_short | Vitamin D deficiency in critically ill COVID-19 ARDS patients |
title_sort | vitamin d deficiency in critically ill covid-19 ards patients |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937427/ https://www.ncbi.nlm.nih.gov/pubmed/33745749 http://dx.doi.org/10.1016/j.clnu.2021.03.001 |
work_keys_str_mv | AT notzquirin vitaminddeficiencyincriticallyillcovid19ardspatients AT herrmannjohannes vitaminddeficiencyincriticallyillcovid19ardspatients AT schlesingertobias vitaminddeficiencyincriticallyillcovid19ardspatients AT krankepeter vitaminddeficiencyincriticallyillcovid19ardspatients AT sittermagdalena vitaminddeficiencyincriticallyillcovid19ardspatients AT helmerphilipp vitaminddeficiencyincriticallyillcovid19ardspatients AT stumpnerjan vitaminddeficiencyincriticallyillcovid19ardspatients AT roederdaniel vitaminddeficiencyincriticallyillcovid19ardspatients AT amreinkarin vitaminddeficiencyincriticallyillcovid19ardspatients AT stoppechristian vitaminddeficiencyincriticallyillcovid19ardspatients AT lotzchristopher vitaminddeficiencyincriticallyillcovid19ardspatients AT meybohmpatrick vitaminddeficiencyincriticallyillcovid19ardspatients |